6 results
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
7 Dec 23
Hepion Pharmaceuticals Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
8:41am
of the Hepion Board.
-1-
Dr. Foster said “I sincerely enjoyed my tenure with the company over the past years. We put our hearts and souls into bringing
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
10 Oct 19
World-Renowned Liver Disease Expert, Dr. Stephen Harrison, Joins Hepion Pharmaceuticals as Consultant Medical Director
11:33am
as a Colonel in the United States Army, retiring in 2016 to conclude 20 years of dedicated service to his country. During his army tenure, he served
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
7 Aug 19
Hepion Pharmaceuticals Welcomes Dr. Stephen Harrison to its Scientific Advisory Board
1:11pm
as a Colonel in the United States Army, retiring in 2016 to conclude 20 years of dedicated service to his country. During his army tenure, he served
8-K
EX-99.1
HEPA
Hepion Pharmaceuticals Inc
20 Jan 15
ContraVir Pharmaceuticals Adds Carol L. Brosgart, M.D., to Scientific Advisory Board
12:00am
President, Public Health and Policy, Vice President, Medical Affairs, and Vice President, Clinical Research. During her tenure leading clinical
8-K
EX-10.1
HEPA
Hepion Pharmaceuticals Inc
15 Jan 15
ContraVir Pharmaceuticals Appoints John Sullivan-Bolyai, M.D., MPH, as Chief Medical Officer
12:00am
, to the extent that Executive’s position, tenure, salary, age, health and other qualifications make Executive eligible to participate in such plans
8-K
EX-10.1
sz3s986l xm5km
26 Jun 14
Departure of Directors or Certain Officers
12:00am
- Prev
- 1
- Next